Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer.
about
A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancerBlood-based biomarkers for monitoring antiangiogenic therapy in non-small cell lung cancer.Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
P2860
Bevacizumab in combination with anticancer drugs for previously treated advanced non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bevacizumab in combination wit ...... ed non-small cell lung cancer.
@en
type
label
Bevacizumab in combination wit ...... ed non-small cell lung cancer.
@en
prefLabel
Bevacizumab in combination wit ...... ed non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Bevacizumab in combination wit ...... ed non-small cell lung cancer.
@en
P2093
Hai-ying Wu
Ke-jun Liu
Ling-yu Ding
P2860
P2888
P304
P356
10.1007/S13277-014-2962-1
P577
2015-03-04T00:00:00Z
P6179
1030052325